Iterum Therapeutics to Present at the 22nd Annual H.C. Wainwright Global Investment Conference

NEXT STORY
Ascendis Pharma A/S Submits Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for TransCon™ hGH for Treatment of Pediatric Growth Hormone Deficiency
PREV STORY
AlloVir Appoints Ercem Atillasoy, M.D., as Chief Regulatory and Safety Officer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Innovation Pharmaceuticals Signs Drug Product Manufacturing Contract with CoreRx to Formulate and Package Brilacidin for Oral Mucositis in Sachet Form

BEVERLY, Mass., July 17, 2018 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a ...

author_avatar
NASDAQ Market News

Curetis and MGI Advance Strategic Partnership in NGS-Based Molecular Microbiology

              Curetis and MGI Advance Strategic Partnership in NGS-Based Molecular Microbiology Inked ...

author_avatar
NASDAQ Market News

Zafgen to Present at the Leerink Partners 6th Annual Global Healthcare Conference

BOSTON, Feb. 09, 2017 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN), a biopharmaceutical company dedicated ...

author_avatar
NASDAQ Market News